BRPI0907805A2 - Combinações para tratar dor associada à hiv - Google Patents
Combinações para tratar dor associada à hivInfo
- Publication number
- BRPI0907805A2 BRPI0907805A2 BRPI0907805-3A BRPI0907805A BRPI0907805A2 BR PI0907805 A2 BRPI0907805 A2 BR PI0907805A2 BR PI0907805 A BRPI0907805 A BR PI0907805A BR PI0907805 A2 BRPI0907805 A2 BR PI0907805A2
- Authority
- BR
- Brazil
- Prior art keywords
- combinations
- treat hiv
- hiv pain
- pain
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08152104 | 2008-02-28 | ||
| PCT/EP2009/052297 WO2009106574A2 (en) | 2008-02-28 | 2009-02-26 | Combinations for treating hiv-associated pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0907805A2 true BRPI0907805A2 (pt) | 2015-07-14 |
Family
ID=39415383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0907805-3A BRPI0907805A2 (pt) | 2008-02-28 | 2009-02-26 | Combinações para tratar dor associada à hiv |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090281194A1 (enExample) |
| EP (1) | EP2257281A2 (enExample) |
| JP (1) | JP2011513278A (enExample) |
| KR (1) | KR20100126441A (enExample) |
| CN (1) | CN101945650A (enExample) |
| AU (1) | AU2009218456A1 (enExample) |
| BR (1) | BRPI0907805A2 (enExample) |
| CA (1) | CA2716405A1 (enExample) |
| EA (1) | EA201001363A1 (enExample) |
| MX (1) | MX2010009507A (enExample) |
| WO (1) | WO2009106574A2 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0148748B1 (ko) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
| GB0012795D0 (en) * | 2000-05-25 | 2000-07-19 | Novartis Ag | Organic compounds |
| GB0028702D0 (en) * | 2000-11-24 | 2001-01-10 | Novartis Ag | Organic compounds |
| US8449908B2 (en) * | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
| GB0504950D0 (en) * | 2005-03-10 | 2005-04-20 | Novartis Ag | Organic compositions |
| WO2007006732A1 (en) * | 2005-07-11 | 2007-01-18 | N.V. Organon | Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist) |
-
2009
- 2009-02-26 JP JP2010548108A patent/JP2011513278A/ja active Pending
- 2009-02-26 KR KR1020107021410A patent/KR20100126441A/ko not_active Withdrawn
- 2009-02-26 AU AU2009218456A patent/AU2009218456A1/en not_active Abandoned
- 2009-02-26 WO PCT/EP2009/052297 patent/WO2009106574A2/en not_active Ceased
- 2009-02-26 BR BRPI0907805-3A patent/BRPI0907805A2/pt not_active IP Right Cessation
- 2009-02-26 MX MX2010009507A patent/MX2010009507A/es not_active Application Discontinuation
- 2009-02-26 EA EA201001363A patent/EA201001363A1/ru unknown
- 2009-02-26 CN CN2009801054260A patent/CN101945650A/zh active Pending
- 2009-02-26 CA CA2716405A patent/CA2716405A1/en not_active Abandoned
- 2009-02-26 EP EP09715296A patent/EP2257281A2/en not_active Withdrawn
- 2009-03-02 US US12/395,980 patent/US20090281194A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009218456A1 (en) | 2009-09-03 |
| JP2011513278A (ja) | 2011-04-28 |
| US20090281194A1 (en) | 2009-11-12 |
| WO2009106574A3 (en) | 2009-12-17 |
| CA2716405A1 (en) | 2009-09-03 |
| EA201001363A1 (ru) | 2011-04-29 |
| EP2257281A2 (en) | 2010-12-08 |
| KR20100126441A (ko) | 2010-12-01 |
| CN101945650A (zh) | 2011-01-12 |
| WO2009106574A2 (en) | 2009-09-03 |
| MX2010009507A (es) | 2010-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0908428A2 (pt) | uso de ranozalina para tratar a dor. | |
| BRPI0915476A2 (pt) | dispositivo para tratar problemas respiratórios | |
| BRPI0816252A2 (pt) | Implemento para cuidado pessoal | |
| BRPI0917126A2 (pt) | implemento para cuidado oral | |
| PT2709604T (pt) | Canabidivarina para utilização no tratamento de dor neuropática | |
| BR112012002269A2 (pt) | implemento para tratar superfície | |
| BRPI0822833A2 (pt) | Implemento para cuidado oral | |
| BR112012001819A2 (pt) | métodos para tratamento de dor | |
| BR112012001604A2 (pt) | composição para cuidado pessoal | |
| BRPI0822817A2 (pt) | Implemento para cuidado oral | |
| BR112012004176A2 (pt) | implemento para cuidado oral | |
| BRPI0907135A2 (pt) | Processos de tratamento de dor crônica | |
| ES2397671T8 (es) | Procedimiento para preparar voriconazol | |
| BR112013011874A2 (pt) | compostos e métodos para tratar dor | |
| BRPI0914614A2 (pt) | 2-arilaminoquinazolinas para tratar doenças proliferativas | |
| BRPI0813670A2 (pt) | Compostos para tratamento | |
| BRDI7106622S (pt) | Configuração aplicada em remédio para alívio de dor | |
| BRPI0822868A2 (pt) | implemento para cuidado oral | |
| BR112012000502A2 (pt) | terapia de combinação para o tratamento de diabetes | |
| BRPI1011226A2 (pt) | métodos para tratar condições relacionadas ao cabelo | |
| BRPI0917552A2 (pt) | kit para o tratamento de onicomicose | |
| BR112012031836A2 (pt) | combinação farmacêutica para o tratamento da dor | |
| BR112012014032A2 (pt) | dispositivo para aparar cabelo | |
| BRPI0810091A2 (pt) | Agentes fugicidas tópicos para tratar distúrbios ungueais | |
| EP3381471C0 (en) | PAIN TREATMENT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |